18
Participants
Start Date
June 27, 2009
Primary Completion Date
January 4, 2011
Study Completion Date
January 4, 2011
BP-C1
"BP-C1, 0.05% solution for injection, will be administered intramuscularly once per day. The cumulative dose range will be 0.64-1.12 mg/kg body weight depending on design level (design level 1-3). The daily dose range will be 0.02-0.035 mg/kg body weight (0.04-0.07 mL/kg) depending on design level (design level 1-3).~Dose level 1: 0.02 mg/kg body weight (0.04 mL/kg) intramuscularly once daily for 32 consecutive days; dose level 2: 0.03 mg/kg body weight (0.06 mL/kg) intramuscularly once daily for 32 consecutive days; dose level 3: 0.035 mg/kg body weight (0.07 mL/kg) intramuscularly once daily for 32 consecutive days.~Changes in the cumulative dose of BP-C1 between patients in the sequence are predefined and will be adjusted by escalation/deescalation rules based on changes in toxicity observed in the previous design level.~The duration of BP-C1 treatment will be 32 days."
Sanglah University Hospital, Bali
National Taiwan University Hospital, Taipei
Siriraj Hospital, Mahidol University, Bangkok
Lead Sponsor
Collaborators (1)
Meddoc
OTHER
Norwegian University of Life Sciences
OTHER
Meddoc Research Indonesia Ltd
UNKNOWN
Meddoc Research Taiwan Ltd
UNKNOWN
Meabco A/S
INDUSTRY